| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-11 16:44 Tx date 2025-11-07 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$726.96
+4 vol $181.74 each |
8,253 | |
| Filed 2025-11-05 17:09 Tx date 2025-11-03 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+126 vol |
8,249 | |
| Filed 2025-09-17 15:58 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,010
+681 vol $4.42 each |
343,674 | |
| Filed 2025-09-17 15:56 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,003
+2,348 vol $6.39 each |
342,993 | |
| Filed 2025-08-12 16:45 Tx date 2025-08-08 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$768.01
+4 vol $192.00 each |
8,123 | |
| Filed 2025-08-07 10:57 Tx date 2025-08-04 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+122 vol |
8,119 | |
| Filed 2025-07-11 16:34 Tx date 2025-04-03 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-908,259.54
-117,498 vol $7.73 each |
1,693,546 | |
| Filed 2025-06-18 16:34 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,439
+699 vol $4.92 each |
340,645 | |
| Filed 2025-06-18 16:33 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$17,256
+2,857 vol $6.04 each |
339,946 | |
| Filed 2025-05-13 18:33 Tx date 2025-05-09 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$855.30
+5 vol $171.06 each |
7,997 | |
| Filed 2025-05-08 18:51 Tx date 2025-05-05 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$22,837
+134 vol $170.43 each |
7,992 | |
| Filed 2025-04-04 19:35 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$323,079
+52,363 vol $6.17 each |
337,089 | |
| Filed 2025-04-04 19:33 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-363,751.78
-69,818 vol $5.21 each |
321,403 | |
| Filed 2025-03-29 16:13 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$731,053
+117,722 vol $6.21 each |
391,221 | |
| Filed 2025-03-29 16:11 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,241,946
+361,022 vol $6.21 each |
1,811,044 | |
| Filed 2025-03-20 15:49 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,797
+555 vol $5.04 each |
284,726 | |
| Filed 2025-03-20 15:48 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,514
+2,260 vol $5.98 each |
284,171 | |
| Filed 2025-02-11 11:08 Tx date 2025-02-07 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$690.48
+5 vol $138.10 each |
7,858 | |
| Filed 2025-02-06 14:25 Tx date 2025-02-03 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$115,099
+824 vol $139.68 each |
7,853 | |
| Filed 2024-12-18 12:15 Tx date 2024-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$19,036
+3,633 vol $5.24 each |
281,911 |